| Drug Name: | xanomeline (131986-45-3) |
|---|---|
| PubChem ID: | 60809 |
| SMILES: | CCCCCCOC1=NSN=C1C2=CCCN(C2)C |
| InchiKey: | JOLJIIDDOBNFHW-UHFFFAOYSA-N |
| Therapeutic Category: |
| Molecular Weight (dalton) | : | 281.425 |
| LogP | : | 3.2161 |
| Ring Count | : | 1 |
| Hydrogen Bond Acceptor Count | : | 5 |
| Hydrogen Bond Donor Count | : | 0 |
| Total Polar Surface Area | : | 38.25 |
This panel provides information on interacting drugs and their ADRs along with references
| Interacting drug | Toxicity | Interaction Type | Mechanism | Reference |
|---|
This panel provides drug-protein interaction and their ADRs along with references
| Toxicity | Interacting Protein | Mechanism | Reference |
|---|---|---|---|
| Bradycardia | Muscarinic acetylcholine receptor M2 (P08172) | Xanomeline produced bradycardia through the low-affinity state of the M(2) receptor [ ADR Type 1 ] | Low-affinity M(2) receptor binding state mediates mouse atrial bradycardia: comparative effects of carbamylcholine and the M(1) receptor aGOnists sabcomeline and xanomeline |
This panel provides drug-food interactions and their ADRs along with references
| Food | Toxicity | Reference |
|---|
This panel provides information on metabolites and their ADRs along with references
| Metabolite | Toxicity | Place of Metabolism | Mechanism | Reference |
|---|
This panel provides information on drug category
| Toxicity | Source |
|---|